Follow
Niloofar Taghizadeh
Niloofar Taghizadeh
Verified email at ucalgary.ca
Title
Cited by
Cited by
Year
US Hospitalizations for Malignant PleuraláEffusions: Data From the 2012 National Inpatient Sample
N Taghizadeh, M Fortin, A Tremblay
Chest 151 (4), 845-854, 2017
1452017
BMI and lifetime changes in BMI and cancer mortality risk
N Taghizadeh, HM Boezen, JP Schouten, CP Schröder, EGE Vries, ...
PloS one 10 (4), e0125261, 2015
1162015
Lifetime smoking history and cause-specific mortality in a cohort study with 43 years of follow-up
N Taghizadeh, JM Vonk, HM Boezen
PloS one 11 (4), e0153310, 2016
1012016
Serum uric acid levels and cancer mortality risk among males in a large general population-based cohort study
N Taghizadeh, JM Vonk, HM Boezen
Cancer Causes & Control 25, 1075-1080, 2014
602014
Low prevalence of high-grade lesions detected with autofluorescence bronchoscopy in the setting of lung cancer screening in the pan-canadian lung cancer screening study
A Tremblay, N Taghizadeh, AM McWilliams, P MacEachern, DR Stather, ...
Chest 150 (5), 1015-1022, 2016
562016
A randomized controlled study of integrated smoking cessation in a lung cancer screening program
A Tremblay, N Taghizadeh, J Huang, D Kasowski, P MacEachern, ...
Journal of Thoracic Oncology 14 (9), 1528-1537, 2019
532019
Health-related quality of life and anxiety in the PAN-CAN lung cancer screening cohort
N Taghizadeh, A Tremblay, S Cressman, S Peacock, AM McWilliams, ...
BMJ open 9 (1), e024719, 2019
342019
Application of lung-screening reporting and data system versus pan-Canadian early detection of lung cancer nodule risk calculation in the Alberta lung cancer screening study
A Tremblay, N Taghizadeh, JH MacGregor, G Armstrong, MS Bristow, ...
Journal of the American College of Radiology 16 (10), 1425-1432, 2019
222019
Objective allergy markers and risk of cancer mortality and hospitalization in a large population-based cohort
N Taghizadeh, JM Vonk, JJ Hospers, DS Postma, EGE de Vries, ...
Cancer Causes & Control 26, 99-109, 2015
202015
Procedures performed during hospitalizations for malignant pleural effusions: data from the 2012 National Inpatient Sample
M Fortin, N Taghizadeh, A Tremblay
Respiration 95 (4), 228-234, 2018
172018
Healthcare professional perspectives on the use of remote patient-monitoring platforms during the COVID-19 pandemic: a cross-sectional study
K Bouabida, K Malas, A Talbot, MÈ Desrosiers, F Lavoie, B Lebouché, ...
Journal of Personalized Medicine 12 (4), 529, 2022
162022
Endosonography-guided transmural drainage of pancreatic fluid collections: comparative outcomes by stent type
A Kayal, N Taghizadeh, T Ishikawa, E Gonzalez-Moreno, S Bass, MJ Cole, ...
Surgical Endoscopy 35, 2698-2708, 2021
162021
What's the score? Do pleural effusion clinical scoring systems help in management of disease?
P Grendelmeier, NM Rahman
Seminars in Respiratory and Critical Care Medicine 40 (03), 394-401, 2019
142019
Healthcare costs and utilization among patients hospitalized for malignant pleural effusion
M Shafiq, X Ma, N Taghizadeh, H Kharrazi, DJ Feller-Kopman, ...
Respiration 99 (3), 257-263, 2020
122020
Lesion heterogeneity and risk of infectious complications following peripheral endobronchial ultrasound
M Fortin, N Taghizadeh, A Chee, CA Hergott, E Dumoulin, A Tremblay, ...
Respirology 22 (3), 521-526, 2017
72017
Tobacco use and motivation to stop smoking among long-term smokers who are ineligible for lung cancer screening
N Taghizadeh, KL Taylor, P MacEachern, R Koetzler, JA Dickinson, ...
Lung cancer 111, 101-107, 2017
62017
Two-year follow-up of a randomized controlled study of integrated smoking cessation in a lung cancer screening program
A Tremblay, N Taghizadeh, P MacEachern, P Burrowes, AJ Graham, ...
JTO Clinical and Research Reports 2 (2), 100097, 2021
42021
MA20. 01 Lung Cancer Screenee Selection by USPSTF versus PLCOm2012 Criteria–Preliminary ILST Findings
M Tammemägi, R Myers, M Ruparel, N Taghizadeh, S Atkar-Khattra, ...
Journal of Thoracic Oncology 13 (10), S425, 2018
42018
Peripheral blood eosinophil counts and risk of colorectal cancer mortality in a large general population-based cohort study.
N Taghizadeh, JM Vonk, HM Boezen
Journal of clinical oncology 29 (15_suppl), 1583-1583, 2011
42011
Buprenorphine/naloxone initiation and referral as a quality improvement intervention for patients who live with opioid use disorder: quantitative evaluation of provincial …
KD Stone, K Scott, BR Holroyd, E Lang, K Yee, N Taghizadeh, J Deol, ...
Canadian Journal of Emergency Medicine 25 (7), 598-607, 2023
32023
The system can't perform the operation now. Try again later.
Articles 1–20